Cetuximab in the treatment of head and neck cancer.

Cetuximab in the treatment of head and neck cancer.

Item
http://www.wikidata.org/entity/Q36668224
Targeting angiogenesis in gynecologic cancersCetuximab in the treatment of head and neck cancer: preliminary results outside clinical trialsThe HER family and cancer: emerging molecular mechanisms and therapeutic targets.Current situation of Panitumumab, Matuzumab, Nimotuzumab and Zalutumumab.Tackling EGFR signaling with TACE antagonists: a rational target for metalloprotease inhibitors in cancer.Incorporation of biologic therapies in the management of gastroesophageal cancersImaging of EGFR and EGFR tyrosine kinase overexpression in tumors by nuclear medicine modalities.A review on the treatment of relapsed/metastatic head and neck cancer.Cost analysis of cetuximab (Erbitux) plus radiotherapy (ERT) versus concomitant cisplatin plus radiotherapy (CRT) within an NHS oncology unit (single institution): a pilot study.Survival outcomes based on systemic agent used concurrently with radiation in human-papillomavirus associated oropharyngeal cancer.EGFR inhibitor C225 increases the radiosensitivity of human lung squamous cancer cells.
P2860

Cetuximab in the treatment of head and neck cancer.

Item
http://www.wikidata.org/entity/Q36668224
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Cetuximab in the treatment of head and neck cancer.
@ast
Cetuximab in the treatment of head and neck cancer.
@en
type
label
Cetuximab in the treatment of head and neck cancer.
@ast
Cetuximab in the treatment of head and neck cancer.
@en
prefLabel
Cetuximab in the treatment of head and neck cancer.
@ast
Cetuximab in the treatment of head and neck cancer.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
Cetuximab in the treatment of head and neck cancer.
@en
P2093
P2860
P304
P31
P356
10.1586/14737140.6.11.1539
P433
P478
P577
P698
P921